US Bancorp’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
US Bancorp's RXST Position: Q1 2026 in Review
US Bancorp reduced its RxSight (RXST) stake by 0.61% in Q1 2026, selling an estimated $25 and leaving 490 shares worth $3.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3710.
US Bancorp first reported a position in RXST in Q4 2023 and has held it in 10 quarters since. The position peaked at $27.1K in Q1 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- US Bancorp held 490 shares of RxSight worth $3.02K as of Q1 2026.
- US Bancorp sold 3 RxSight shares in Q1 2026, an estimated $25.
- RxSight made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3710 holding.
- US Bancorp first reported a position in RxSight in Q4 2023 and has held it in 10 quarters since.
- US Bancorp's RxSight position peaked at $27.1K in Q1 2024.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.